Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells
✍ Scribed by Oh, Youngman; Gucev, Zoran; Ng, Lilly; Müller, Hermann L.; Rosenfeld, Ron G.
- Book ID
- 119178576
- Publisher
- Elsevier Science
- Year
- 1995
- Weight
- 633 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0955-2235
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Variability in response to chemotherapy is poorly understood. Paclitaxel-induced apoptosis was assessed in human Hs578T breast cancer cells, using the MTT assay, cell counting, morphological features and flow cytometry. Pre-dosing cells with non-glycosylated insulin-like growth factor binding protei
## Abstract The influence of a human insulin‐like growth factor binding protein, hIGFBP‐1, on the action of IGFs on human osteosarcoma cells was examined. hIGFBP‐1 was found to block binding of IGFs to their receptors on MG‐63 cells and subsequent IGF stimulation of DNA synthesis. Concurrent incuba
The mitogenic effects of insulin-like growth factors (IGFs) are regulated by a family of insulin-like growth factor binding proteins (IGFBPs). One member of this family, IGFBP-3, mediates the growth-inhibitory and apoptosis-inducing effects of a number of growth factors and hormones such as transfor